179 related articles for article (PubMed ID: 9686628)
21. [Sclerosing peritonitis without reduced ultrafiltration as complication of peritoneal dialysis].
von Schnakenburg C; Pohl M; Häffner K; Zimmerhackl LB; Brandis M
Klin Padiatr; 2005; 217(1):41-4. PubMed ID: 15640972
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of ultrafiltration failure.
Korbet SM
Adv Ren Replace Ther; 1998 Jul; 5(3):194-204. PubMed ID: 9686630
[TBL] [Abstract][Full Text] [Related]
23. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
Vychytil A; Herzog R; Probst P; Ribitsch W; Lhotta K; Machold-Fabrizii V; Wiesholzer M; Kaufmann M; Salmhofer H; Windpessl M; Rosenkranz AR; Oberbauer R; König F; Kratochwill K; Aufricht C
Kidney Int; 2018 Dec; 94(6):1227-1237. PubMed ID: 30360960
[TBL] [Abstract][Full Text] [Related]
25. Morpho-functional study of peritoneum in peritoneal dialysis patients.
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
J Nephrol; 2003; 16(3):373-8. PubMed ID: 12832736
[TBL] [Abstract][Full Text] [Related]
26. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.
Gandhi VC; Humayun HM; Ing TS; Daugirdas JT; Jablokow VR; Iwatsuki S; Geis WP; Hano JE
Arch Intern Med; 1980 Sep; 140(9):1201-3. PubMed ID: 7406618
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of encapsulating peritoneal sclerosis.
Pollock CA
Perit Dial Int; 2001; 21 Suppl 3():S61-6. PubMed ID: 11887865
[TBL] [Abstract][Full Text] [Related]
28. [Sclerosing peritonitis].
Wanic-Kossowska M; Grzegorzewska A
Pol Arch Med Wewn; 1991 Sep; 86(3):189-92. PubMed ID: 1808603
[No Abstract] [Full Text] [Related]
29. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
[TBL] [Abstract][Full Text] [Related]
30. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
[TBL] [Abstract][Full Text] [Related]
31. [Anatomic-functional correlation of the peritoneal membrane].
del Peso G; Jiménez-Hefferman JA; Bajo MA; Sánchez-Villanueva R; Tabernero A; Aroeira L; Selgas R
Nefrologia; 2008; 28 Suppl 6():11-6. PubMed ID: 18957006
[TBL] [Abstract][Full Text] [Related]
32. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients.
Hoshii S; Honda M; Itami N; Oh S; Matsumura C; Moriya S; Mori M; Hatae K; Ito Y; Karashima S
Pediatr Nephrol; 2000 Apr; 14(4):275-9. PubMed ID: 10775068
[TBL] [Abstract][Full Text] [Related]
33. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
34. Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis.
Baroni G; Schuinski A; de Moraes TP; Meyer F; Pecoits-Filho R
Mediators Inflamm; 2012; 2012():912595. PubMed ID: 22547910
[TBL] [Abstract][Full Text] [Related]
35. Biocompatible peritoneal dialysis solutions: do we have one?
Chaudhary K; Khanna R
Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
[TBL] [Abstract][Full Text] [Related]
36. [Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].
Penar J; Weyde W; Krajewska M; Madziarska K; Gołebiowski T; Szymczak M; Kłak R; Klinger M
Postepy Hig Med Dosw (Online); 2009 Apr; 63():200-4. PubMed ID: 19502680
[TBL] [Abstract][Full Text] [Related]
37. [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms].
Kowalewska J; Lichodziejewska-Niemierko M; Liberek T; Mechlińska-Baczkowska J; Nałecz A; Jaśkiewicz K; Rutkowski B
Wiad Lek; 2006; 59(5-6):419-21. PubMed ID: 17017495
[TBL] [Abstract][Full Text] [Related]
38. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
[TBL] [Abstract][Full Text] [Related]
39. Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network.
Aufricht C; Beelen R; Eberl M; Fischbach M; Fraser D; Jörres A; Kratochwill K; LópezCabrera M; Rutherford P; Schmitt CP; Topley N; Witowski J
Kidney Int; 2017 Oct; 92(4):824-835. PubMed ID: 28797473
[TBL] [Abstract][Full Text] [Related]
40. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
